This inventor holds 3 USPTO granted patents. Top assignee: Washington State University. Active years: 1999-2008.
Company Filing History:
Years Active: 1999-2008
Title: Innovations of Charles Cullen Burke
Introduction
Charles Cullen Burke is a notable inventor based in Moscow, ID (US). He has made significant contributions to the field of biochemistry, particularly in the area of geranyl diphosphate synthase. With a total of 3 patents, Burke's work has implications for various applications in biotechnology.
Latest Patents
Burke's latest patents include innovations related to geranyl diphosphate synthase molecules and nucleic acid molecules encoding the same. One of his inventions provides isolated nucleic acid molecules that encode a geranyl diphosphate synthase protein. These molecules are designed to hybridize to specific nucleic acid sequences under defined conditions. Additionally, he has developed methods for altering the expression levels of geranyl diphosphate synthase proteins in host cells. Another significant patent involves the isolation and sequencing of a cDNA encoding the large subunit of geranyl diphosphate synthase from peppermint. This work includes the provision of replicable recombinant cloning vehicles that code for this large subunit, as well as modified host cells that have been transformed with these vehicles.
Career Highlights
Charles Cullen Burke is affiliated with Washington State University, where he conducts his research and development activities. His work has been instrumental in advancing the understanding of geranyl diphosphate synthase and its applications in various fields.
Collaborations
Burke has collaborated with notable colleagues such as Rodney Bruce Croteau and Mark R Wildung. These collaborations have further enriched his research and contributed to the advancements in his field.
Conclusion
Charles Cullen Burke's innovative work in the field of biochemistry, particularly regarding geranyl diphosphate synthase, showcases his significant contributions to science and technology. His patents reflect a commitment to advancing knowledge and applications in biotechnology.